Eloxx Pharmaceuticals, Inc. · NASDAQ:ELOX
Domicilium Capital Partners LLC reported a 19.99% stake in Eloxx Pharmaceuticals, Inc. (Schedule 13G)
Event Jun 5, 2026 · Filed Jun 17, 2026
Domicilium Capital Partners LLC reported a 19.99% stake in Eloxx Pharmaceuticals, Inc., 854,973 shares, as a passive investor on Jun 5, 2026. Filed Jun 17, 2026 (Schedule 13G).
- Stake
- 19.99%
- Shares
- 854,973
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Domicilium Capital Partners LLC | 19.99% | 854,973 |
| Domicilium Real Estate Fund III LP | 5.90% | 238,422 |
| Domicilium Real Estate Fund III GP LLC | 5.90% | 238,422 |
| BKJLAGG, LLC | 14.10% | 602,266 |
| MSEK Charleston LLC | 5.60% | 240,688 |
| Bold Stroke Investments, LLC | 5.60% | 240,688 |
| Daniel Simon | 19.99% | 854,973 |
Source
Related
- Eloxx Pharmaceuticals, Inc.
- Domicilium Capital Partners LLC
- Eloxx Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Domicilium Capital Partners LLC · Jun 5, 2026
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Srinivas Akkaraju · Aug 14, 2026
- Schedule 13G · EcoR1 Capital, LLC · Jun 16, 2026
- Schedule 13G · Stonepine Capital Management, LLC · Jun 16, 2026
- Schedule 13G · Invus Public Equities, L.P. · Jun 15, 2026